Skin Cancer Treatment Market Size, & Share Outlook 2030
市场洞察和分析师观点：
皮肤癌治疗市场预测可以帮助该市场的利益相关者规划其增长战略。黑色素瘤和非黑色素瘤都是皮肤癌类型。过多的阳光照射会导致皮肤癌。根据美国皮肤病学会的数据，五分之一的美国人患有皮肤癌。此外，据该组织称，每年有近 300 万美国人被诊断出患有非黑色素瘤皮肤癌。黑色素瘤和非黑色素瘤皮肤癌的患病率不断上升，推动了市场收入。
免疫治疗、靶向治疗、化疗和放射治疗是皮肤癌的可用治疗方法。此外，5-氟尿嘧啶乳膏被归类为化疗的一种形式，用于这种治疗。然而，由于手术是皮肤癌更有效的治疗方法，因此它是首选选择此外，皮肤癌治疗市场趋势包括不断增加的管道药物。
增长动力和挑战：
黑色素瘤和非黑色素瘤的患病率不断增加推动皮肤癌治疗市场规模。黑色素瘤和非黑色素瘤患病率的不断增加已成为推动市场增长和多样化的重要驱动力。由于皮肤癌患病率的不断上升和公众意识的提高，用于治疗皮肤癌的药物数量最近有所增加。根据美国国家医学图书馆2022年发布的最新数据，美国每年记录180万例鳞状细胞癌（SCC）和360万例基底细胞癌（BCC）病例。皮肤癌发病率的上升推动了对皮肤癌治疗的需求。
近年来，由于全球变暖的加速，人们接触紫外线的情况有所增加。在臭氧消耗较严重的地区，居民皮肤癌病例数有所增加。澳大利亚癌症委员会报告称，由阳光照射引起的皮肤癌占该国每年报告的所有癌症病例的 80% 以上。该组织补充说，美国、英国和加拿大的皮肤癌发病率最高。此外，老年人口特别容易患皮肤癌。预计这些地区老年人口的增加将支持市场的扩张。
由于现有治疗方式的不利影响，影响了市场的增长，皮肤癌治疗市场面临着重大挑战。手术、化疗、放射治疗和免疫治疗等常规治疗方案可能会导致不良反应，包括皮肤刺激、全身毒性、长期并发症等。这些副作用会显着影响患者的生活质量，并可能阻止一些人寻求或坚持治疗。此外，当前治疗方案的局限性可能促使人们需要探索替代性、侵入性较小、更有针对性的皮肤癌治疗方法。由于研发活动的重点是推进治疗方式，提高安全性和有效性，市场将见证应对这些挑战的变革性创新，为患者带来新的希望并推动市场的扩张。因此，现有治疗方式的不利影响阻碍了皮肤癌治疗市场的增长。
报告细分和范围：
“皮肤癌治疗市场分析”已考虑以下细分市场进行：根据类型、治疗方法和最终用户。根据类型，市场分为黑色素瘤和非黑色素瘤。皮肤癌治疗市场按疗法分为免疫疗法、靶向疗法、化疗、放射疗法等。按最终用户划分，市场分为医院、皮肤科诊所、诊断中心等。从地域来看，皮肤癌治疗市场报告分为北美（美国、加拿大和墨西哥）、欧洲（英国、德国、法国、意大利、西班牙和欧洲其他地区）、亚太地区（中国） 、日本、印度、澳大利亚、韩国和亚太地区其他地区）、中东和非洲（阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区）以及南美洲和中美洲（巴西） 、阿根廷以及南美洲和中美洲其他地区）。
细分分析：
根据类型，皮肤癌治疗市场分为黑色素瘤和非黑色素瘤。预计黑色素瘤细分市场在预测期内将占据更大的市场份额。皮肤上的黑色素细胞异常分裂，称为黑色素瘤皮肤癌。几个亚洲和欧洲国家黑色素瘤发病率的上升促进了该领域的市场增长。手术和放射治疗是非黑色素瘤皮肤癌的主要治疗方法。尽管如此，预计用于治疗黑色素瘤以外的皮肤癌的免疫治疗药物的推出将支持未来几年该领域的市场扩张。随着非黑色素瘤治疗药物的广泛普及，预计该市场将在未来几年增长。
根据治疗，皮肤癌治疗市场分为免疫疗法、靶向疗法、化疗、放射疗法等。考虑到放疗和化疗的副作用，免疫治疗药物越来越多地用于治疗皮肤癌。此外，靶向治疗等治疗方案可以提高皮肤癌治疗的成功率。当皮肤癌发展到其他治疗方案不可行时，医生会建议免疫疗法和靶向治疗。预计这些因素将在未来几年推动靶向治疗和免疫治疗领域的皮肤癌治疗市场增长。此外，预计到 2030 年，靶向治疗领域将占据重要的皮肤癌治疗市场份额。
区域分析：
根据区域，皮肤癌治疗市场分为北美、欧洲、亚太地区、中东地区东部和非洲以及南美洲和中美洲。
北美是皮肤癌治疗市场增长的最重要贡献者，因为美国皮肤癌的发病率较高，并且该国对癌症药物的使用较多。此外，预计主要行业参与者引入皮肤癌新疗法的倾向将对该地区市场的扩张产生有利影响。由于非黑色素瘤皮肤癌在白种人群体中更为常见，北美和欧洲占据了全球市场的很大一部分。
亚太地区的皮肤癌治疗市场规模预计在预测期间将以最高速度增长由于澳大利亚和新西兰等国家黑色素瘤和非黑色素瘤的患病率不断上升。在亚太地区，皮肤癌药物的监管批准以及发展中国家庞大且不发达的市场支持了该地区皮肤癌治疗市场的扩张。随着欧洲黑色素瘤病例的增加，预计市场收入在预测期内将健康发展。
行业发展和未来机遇：
列出了全球皮肤癌治疗市场主要参与者采取的一些举措如下：
2023年10月，随着美国FDA批准Opdivo（nivolumab），百时美施贵宝宣布现在可以作为辅助治疗完全切除的IIB或IIC期黑色素瘤的成人和12岁及以上儿童患者。这扩大了 Opdivo 目前的适应症，并进一步巩固了该公司为黑色素瘤患者提供治疗选择的传统。 3 期 CheckMate -76K 试验将 Opdivo（n = 526）与安慰剂（n = 264）进行对比，作为批准的基础。 2023 年 3 月，Zynyz，一种针对程序性死亡受体-1 的人源化单克隆抗体（PD-1）被美国食品和药物管理局（FDA）批准用于治疗成人转移性或复发性局部晚期默克尔细胞癌（MCC）。基于肿瘤缓解率和缓解持续时间（DOR），FDA在加速审批下批准了Zynyz；然而，Zynyz 对该适应症的持续批准可能需要验证试验中的临床益处的验证和描述。竞争格局和主要公司：
默克公司、布里斯托尔迈尔斯施贵宝、诺华公司、罗氏公司、安进公司、葛兰素史克（GSK）、辉瑞公司（Pfizer Inc.）、太阳制药（Sun Pharmaceutical）和再生元制药（Regeneron Pharmaceuticals）是皮肤癌治疗市场报告中的几家主要公司。这些公司专注于扩大产品范围，以满足全球不断增长的消费者需求。他们的全球业务使他们能够为许多客户提供服务，从而扩大他们的市场份额。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The light therapy market was valued at US$ 10,388.57 million in 2022.
The light therapy market has major market players, including Merck & Co., Bristol Mayers Squibb, Novartis AG, Roche, Amgen Inc., GSK, Pfizer Inc., Sun Pharmaceutical, and Regeneron Pharmaceuticals.
Melanoma and non-melanoma are skin cancer types. Excessive sunlight exposure can cause skin cancer. As per the American Academy of Dermatology Association, skin cancer affects one in five Americans. Furthermore, according to the group, almost 3 million Americans receive a diagnosis of non-melanoma skin cancer annually. Growing prevalence of melanoma and non-melanoma skin cancer drives the market revenue.
Based on therapy, the skin cancer treatment market is segmented into immunotherapy, targeted therapy, chemotherapy, radiation therapy, and others. Considering the adverse effects of radiation and chemotherapy, immunotherapy medications are being utilized more often to treat skin cancer. Furthermore, treatment options, such as targeted therapy, improve skin cancer treatment success. When skin cancer has advanced to the point where other treatment options are not practical, physicians propose immunotherapy and targeted therapy. It is expected that these factors will boost the skin cancer treatment market growth for the targeted therapy and immunotherapy segments in the coming years.
The light therapy market is expected to be valued at US$ 18,277.71 million in 2030.
Based on type, the skin cancer treatment market is bifurcated into melanoma and non-melanoma. The melanoma segment is expected to hold a larger market share during the forecast period. Melanocytes on the skin divide abnormally, known as melanoma skin cancer. Rising incidence of melanoma in several Asian and European countries bolsters the market growth for the segment. Surgery and radiation therapy are main treatments for non-melanoma skin cancer. Nonetheless, the launch of immunotherapy medications to treat skin cancer other than melanoma is anticipated to support the market expansion for the segment in the next years. The market is expected to grow in the coming years as therapeutic medications for non-melanoma treatment become widely available..
The increasing prevalence of melanoma and non-melanoma has emerged as a significant driver propelling the growth and diversification of the skin cancer treatment market. The number of medications used to treat skin cancer has increased recently as a result of the growing prevalence of the disease and rising public awareness.
The List of Companies - Skin Cancer Treatment Market
- Elekta
- Novartis AG
- F.Hoffmann La-Roche Ltd.
- Dermacure-rt
- Xoft (iCAD, Inc.)
- Merck KGaA
- GalaxoSmithKline plc.
- Amgen, Inc.
- Eli Lily and Company
- Sun PharmaceuticalsMerck & Co.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For